News
Cetero Reaches Final Resolution with the Food and Drug Administration
Cary, NC – (April 24, 2012) – Leading early-phase Contract Research Organization (CRO) Cetero Research today announced it has reached a final resolution with the U.S. Food and Drug Administration (FDA) over studies the company conducted in its Houston bioanalytical laboratory between April 1, 20...
Cetero Research Grows Senior Management Team
Cary, NC – December 20, 2011 – Cetero Research, the leading early-stage contract research organization, today announced two new appointments to its senior management team. Michael C. Fillios was named Chief Administrative Officer, with leadership responsibility and oversight of Human Resources,...
Cetero Research Names 25-Year Industry Veteran James Dixon to Head Quality and Compliance
April 26, 2011 – Cetero Research, the leading early-stage contract research organization (CRO), today announced the appointment of James "Jay" Dixon to Senior Vice President, Quality and Compliance. Dixon has spent more than 25 years in the pharmaceutical, biotechnology and CRO industries, and wil...
Cetero Research Announces Completion of 20,000th Early-Phase Clinical Study
January 27, 2011 – Cetero Research, the leading early-stage contract research organization (CRO), today announced that it has reached another industry milestone with the completion of its 20,000th early-phase clinical study. This achievement solidifies Cetero's position as the unmatched leader in...
Cetero Research Expands Business Development in Europe
November 16, 2010 – Cetero Research, the leading early-stage contract research organization (CRO), today announced the appointment of Marcus Pullen as Senior Director, Business Development, based in the United Kingdom. Pullen will be Cetero’s first business development representative in Europe f...
Cetero Research Launches Seminar Series on Accelerated Proof-of-Concept in Drug Development
September 2, 2010 – Cetero Research, the leading early-stage contract research organization (CRO), is launching a series of scientific seminars, “An Accelerated Path to Proof-of-Concept in Drug Development,” designed to help pharmaceutical and biotechnology researchers learn the latest innovat...
Cetero Research Announces Expansion of TDDS and Dermatology Services to Four Clinical Facilities
August 19, 2010 – Cetero Research, the leading early-stage contract research organization (CRO), today announced the expansion of multiple Clinical Dermatology and Transdermal Delivery System (TDDS) services to four Cetero clinical facilities. Cetero has also enhanced the sophistication of its pre...
Cetero Research Uses Accelerated POC Study Design to Speed Drug Development; Cut Costs
June 8, 2010 – Cetero Research, the leading early-stage contract research organization (CRO), today announced its success in using an innovative approach to Phase I and Phase II clinical trials to cut study time by 50 percent and reduce costs by more than 10 percent. The accelerated POC (AcPOC) st...
Cetero Research Leads Industry in Human Allergy Models
May 25, 2010 – Cetero Research, the leading early-stage contract research organization (CRO), announced today that it has more Environmental Exposure Chambers (EECs), or allergy models for recreating environmental conditions than any other CRO. Over the past nine years, Cetero has used these model...
Cetero Research Leads the Industry with 50th Definitive TQT Trial
May 11, 2010 – Cetero Research, the leading early-stage contract research organization (CRO), today announced it has completed its 50th definitive TQT trial in the last eight years. Cetero’s specialized experience conducting these complex studies assures its clients accurate cardiac safety asses...
